Themis Medicare Ltd (THEMISMED) โ Sustainability Report | 8 September 2026
Themis Medicare Limited (THEMISMED) filed its Business Responsibility and Sustainability Report (BRSR) as part of the Annual Report for FY2025-26. The filing includes details of the 56th Annual General Meeting (AGM) scheduled for 30th September 2026, financial performance showing consolidated revenue of Rs. 342.24 crores (down from Rs. 405.51 crores in FY25), EBITDA of Rs. 0.39 crores, and PAT of Rs. 1.14 crores. The report highlights strategic focus on hospital business growth, cost rationalization, and ESG initiatives. It also covers governance practices, CSR activities, risk disclosures, and compliance with SEBI regulations. Key events include a proposed preferential issue of convertible warrants and amendments to the Articles of Association. The filing emphasizes stakeholder engagement, regulatory compliance, and sustainability commitments.
About Themis Medicare Ltd (THEMISMED)
Healthcare ยท Pharmaceuticals ยท Listed on BSE
๐ก Get AI alerts when THEMISMED files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track THEMISMED โ Free๐ก Ask AI about this filing
๐ More THEMISMED filings
- ๐ด Corporate Action โ 24 September 2026Themis Medicare Limited withdrew its proposed preferential issue of 4,595,795 convertible warrants p...
- Announcement โ 23 September 2026Themis Medicare Limited announced that its trading window will close on 1 October 2026 due to SEBI i...
- ๐ด Corporate Action โ 18 September 2026Themis Medicare announced a record date of September 23, 2026, for final dividend entitlement for FY...
- Announcement โ 17 August 2026Themis Medicare Limited updated its official email addresses for corporate correspondence and regist...
- ๐ก Board Meeting โ 13 August 2026Themis Medicare announced the outcome of its board meeting held on 13 August 2026, where it approved...
๐ฅ Also filed on 8 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when THEMISMED files new disclosures
Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track THEMISMED โ FreeFree account ยท 2 AI queries/day